Vaxcyte, Inc.
PCVXDrugs in Pipeline
7
Phase 3 Programs
3
Upcoming Catalysts
3
Next Catalyst
Jan 2027
Market Overview
Stock performance and key metrics
3 upcoming, 0 past
How PCVX's past catalysts played out
31 valent pneumococcal conjugate vaccine
Pneumococcal Vaccines
PCV20
Pneumococcal Vaccines
31-valent pneumococcal conjugate vaccine
Pneumococcal Vaccines
0.5 mL of the low dose VAX-31
Pneumococcal Vaccines
24-Valent Pneumococcal Conjugate Vaccine
Pneumococcal Vaccines
24 valent pneumococcal conjugate vaccine
Pneumococcal Vaccines
0.5 ml dose of 1.1 mcg VAX-24
Pneumococcal Vaccines
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
31 valent pneumococcal conjugate vaccine | Phase 3 | Pneumococcal Vaccines | - | - |
PCV20 | Phase 3 | Pneumococcal Vaccines | - | - |
31-valent pneumococcal conjugate vaccine | Phase 3 | Pneumococcal Vaccines | - | - |
0.5 mL of the low dose VAX-31 | Phase 2 | Pneumococcal Vaccines | - | - |
24-Valent Pneumococcal Conjugate Vaccine | Phase 2 | Pneumococcal Vaccines | - | - |
24 valent pneumococcal conjugate vaccine | Phase 2 | Pneumococcal Vaccines | - | - |
0.5 ml dose of 1.1 mcg VAX-24 | Phase 2 | Pneumococcal Vaccines | - | - |
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Full breakdown — the signals behind the verdict
Frequently asked questions
What is in Vaxcyte, Inc.'s drug pipeline?→
CatalystAlert tracks 7 drug candidates in Vaxcyte, Inc.'s (PCVX) pipeline across Phase 3, Phase 2. Its lead program is 31 valent pneumococcal conjugate vaccine (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Vaxcyte, Inc.'s next FDA catalyst?→
Vaxcyte, Inc.'s (PCVX) next tracked catalyst is a Phase 3 expected January 15, 2027. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track PCVX biotech catalysts?→
Add PCVX to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Vaxcyte, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.